For Partners

SCRI is the only oncology research organization of its kind to offer end-to-end clinical trial site management, contract research services for biopharma and personalized medicine advisory services in one place. As a leader in drug development, SCRI has conducted nearly 750 first-in-human trials to date. More than 4,500 patients enroll to our early and late-phase trials every year.


Opinion Leaders
Learn More
CRO Navigation
Learn More
SMO Navigation
Learn More
Personal Medicine
Learn More

Scientific Key Opinion Leaders:

Our world-renowned physician research leaders, trained at the top academic institutions, deliver valuable insights into the optimal execution of all aspects of clinical research.

Meet Our Leadership Team


Oncology-Focused Contract Research Organization (CRO):

Contracted by biopharma to design, manage and monitor trials as well as analyze results

From Pre-Clinical to Post-Approval, SCRI Development Innovations delivers end-to-end CRO capabilities:

  • As a part of SCRI, we leverage expert physician expertise to design and implement clinical trials to advance therapies and improve the lives of patients fighting cancer.
  • We work in tandem with SCRI’s centralized SMO to design and deliver timely site activation, patient recruitment and overall study delivery.
  • Powered by Genospace’s precision medicine technology, our personalized medicine expertise informs clinical development approaches every step of the way.

Oncology Expertise
Oncology Expertise in the Following Areas:
  • Clinical Development
  • Strategic Planning & Oversight
  • Clinical Monitoring
  • Medical Monitoring
  • Medical Writing & Publishing
 
  • Pharmacovigilance
  • Regulatory Affairs
  • Data Management
  • Project Management
  • Biostatistics
 

Differentiators:

  • Strategic Site Relationship & Expedited Start-up – We’re able to leverage existing relationships and infrastructure with SCRI sites to achieve expedited start-up in as little as 6 weeks
  • Unique Personalized Medicine & Data Capabilities – SCRI’s Personalized Medicine program offers scientific consultative services to drug development partners to enrich clinical development insights

 

 

Partnerships
Contact Us
News
Newsroom

Centralized Site Management Organization:

Partner with a network of sites where physicians enroll and treat patients on clinical trials:

  • SCRI’s Site Management Organization (SMO) offers operational and other centralized research support services for sites on phase I through III industry-sponsored and investigator-initiated trials.
  • The SMO offers support services for trials across tumor types including highly specialized expertise in complex GI, lung, breast/gynecologic, central nervous system, genitourinary, melanoma and blood cancers. Additionally, the SMO works with FACT-accredited transplant sites to advance cellular therapy research inclusive of CAR T-Cell, CRISPR and other novel approaches.

SCRI Centralized Site Support Services

Program Development
Regulatory
Contracting
Protocol
Education
Technology
Financial

Our Differentiators:

 

SMO Differentiators
  • Rapid study activation timelines
  • Community clinic-based model at SCRI sites provides access to larger numbers of patients
  • Efficiencies with budget, contract, and informed consent
  • Utilization of central IRBs
  • Standardized SOPs and quality metrics across all SCRI sites
  • Partners with the Personalized Medicine team to rapidly identify patients for trials
 

 


Personalized Medicine Program Includes:

Personalized Medicine Program  

Site Support

  • Patient-Centric Clinical Trial Matching
  • Molecular Cancer Conferences: SCRI’s Molecular Tumor Boards
  • MolecularHelp Consultation: On Demand Reviews of NGS Reports
  • Molecular Education
  • Variant Annotation
  • Clinical Trial incl/excl criteria
  • Drug MOA sensitivity

 

 

Partner Support

  • Feasibility Analysis
  • Real World Data Analytics
  • Data-driven Study Design
  • On Study Analytics
  • Scientific Consultative Services
 

 

 

 

Contact Us

Email